For decades, the narrative surrounding China's pharmaceutical industry was clear and singular: it was the world's factory for cost-efficient generics. This reputation, however, is undergoing a seismic

The narrative of global pharmaceutical innovation is being rewritten, with a dynamic new chapter emerging from China. No longer just a hub for generic manufacturing or clinical trial services, the…

In the sprawling landscape of global health innovation, a seismic shift is underway, and its epicenter is increasingly found in China. For decades, the nation was primarily seen as the…

The narrative of China’s pharmaceutical sector has fundamentally changed. For decades, the industry was synonymous with high-volume generic drug manufacturing, serving as the world’s pharmacy for cost

In a significant development for China's rapidly evolving biopharmaceutical sector, the National Medical Products Administration (NMPA) has granted marketing approval to Jiangsu Vcare PharmaTech's inn

In a significant move that underscores China's rising prowess in biopharmaceutical innovation, Shanghai-based Mabwell Therapeutics has announced a major regulatory milestone. The company's independent